Full Text View
Tabular View
No Study Results Posted
Related Studies
Hydroxyurea to Prevent Organ Damage in Children With Sickle Cell Anemia
This study is ongoing, but not recruiting participants.
Study NCT00006400   Information provided by National Heart, Lung, and Blood Institute (NHLBI)
First Received: October 12, 2000   Last Updated: October 14, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hematologic Diseases
Anemia, Sickle Cell
Additional conditions recognized in this trial
Anemia
More general conditions related to this trial
Anemia, Hemolytic
Anemia, Hemolytic, Congenital
Genetic Diseases, Inborn
Hemoglobinopathies
Interventions listed in this trial
Hydroxyurea
Placebo
More general drug interventions related to this trial
Antineoplastic Agents
Antisickling Agents
Enzyme Inhibitors
Hematologic Agents
Molecular Mechanisms of Pharmacological Action
Nucleic Acid Synthesis Inhibitors
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
National Heart, Lung, and Blood Institute (NHLBI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services